Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Cannabis Access topic
No spam. Unsubscribe anytime.
House panel advances medical cannabis changes, adopts reciprocity amendment and lays bill over
Summary
The House Commerce Committee heard testimony on House File 16-72, an Office of Cannabis Management (OCM) bill that would update Minnesota's medical cannabis rules, adopted an A2 amendment establishing visiting-patient reciprocity and protections, and laid the bill over for referral to Judiciary, Finance and Civil Law.
House File 16-72, an Office of Cannabis Management policy bill that would make technical and patient-protection changes to Minnesota's medical cannabis program, was presented Tuesday to the Minnesota House Commerce Committee and laid over for possible inclusion in an omnibus bill after the panel adopted an author's amendment expanding patient reciprocity.
The measure, introduced by Representative Breyer and discussed by Interim Director Eric Taubel of the Office of Cannabis Management, aims to smooth the transition from the existing Chapter 152 medical cannabis framework into the new licensing structure for adult-use and medical programs. "The top line thing it does is ensure patient access through streamlining and making available the use of virtual consultation for patients," Taubel said, noting the change would allow remote pharmacist or consultant review when on-site staff are unavailable.
The committee adopted the A2 author's amendment, which Representative Breyer said "establishes access for visiting patients" by creating reciprocity for non-Minnesota residents and ensuring tribal medical patients retain current access under Chapter 152. Taubel told the committee the amendment also aligns protection language in the bill and strengthens registry privacy and anti-discrimination protections: "Our customer service team says they get about 25 emails a week with people who are concerned about school, their landlord, health care facilities or employers."
No members of the public testified on the bill at the Commerce Committee hearing. After discussion the committee voted to lay House File 16-72 over for possible inclusion and to re-refer the bill, as amended, to the Judiciary, Finance and Civil Law Committee.
Members emphasized the bill's aim to preserve patient access during the regulatory transition and to clarify technical inconsistencies in statutory language. The Office of Cannabis Management said it intends the changes to be largely conforming and protective of existing medical program participants.
The bill's future steps include committee consideration in the receiving committee and continued work on language to ensure a seamless shift from Chapter 152 to the new licensing framework.
